APA (7th ed.) Citation

Suzuki, R., Hamada, K., Hamada, K., Ohkuma, R., Homma, M., Tsurui, T., . . . Tsunoda, T. (2023, July). Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary. Frontiers in Oncology.

Chicago Style (17th ed.) Citation

Suzuki, Risako, et al. "Case Report: Combined Pembrolizumab, 5-fluorouracil, and Cisplatin Therapy Were Remarkably Effective in P16-positive Squamous Cell Carcinoma of Unknown Primary." Frontiers in Oncology Jul. 2023.

MLA (9th ed.) Citation

Suzuki, Risako, et al. "Case Report: Combined Pembrolizumab, 5-fluorouracil, and Cisplatin Therapy Were Remarkably Effective in P16-positive Squamous Cell Carcinoma of Unknown Primary." Frontiers in Oncology, Jul. 2023.